Erythromyeloid derived TREM2: a major determinant of Alzheimer’s disease pathology in Down syndrome

MLA

Raha-Chowdhury, Ruma, et al. Erythromyeloid Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome. Jan. 2018. EBSCOhost, https://doi.org/10.17863/cam.18342.

APA

Raha-Chowdhury, R., Henderson, J. W., Raha, A. A., Stott, S. R., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., Devalia, V., Friedland, R. P., Holland, A., & Zaman, S. H. (2018). Erythromyeloid derived TREM2: a major determinant of Alzheimer’s disease pathology in Down syndrome. https://doi.org/10.17863/cam.18342

Chicago

Raha-Chowdhury, Ruma, James W Henderson, Animesh Alexander Raha, Simon RW Stott, Romina Vuono, Simona Foscarin, Liam Wilson, et al. 2018. “Erythromyeloid Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome,” January. doi:10.17863/cam.18342.